UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RLAY — Relay Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,207,494
+$3,113,340 QoQ
Shares Held
278,327
+32.2% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. RLAY ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,207,494 | 278,327 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,094,154 | 210,468 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,775,310 | 209,848 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,055,711 | 202,244 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,414,796 | 408,902 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $790,058 | 301,550 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $958,235 | 232,582 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,580,883 | 223,289 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,366,907 | 209,649 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,625,554 | 557,296 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,268,940 | 841,866 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,278,471 | 865,455 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $11,134,964 | 886,542 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,601,341 | 886,542 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,191,005 | 815,998 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $18,557,254 | 829,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,092,517 | 781,643 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,193,194 | 574,447 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,894,569 | 615,258 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,385,774 | 234,246 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,595,396 | 262,241 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,707,838 | 425,451 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,131,455 | 484,395 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $10,839,537 | 254,509 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||